PATHFINDER CELL THERAPY, INC. — Operating Income by Fiscal Year
5 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/c89cd73b-168a-467d-8539-90d7281dedef/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2014 | $-1.1M | 2014-01-01 – 2014-12-31 | evidence 0001213900-15-002271 |
| FY 2013 | $-17.4M | 2008-11-05 – 2014-03-31 | evidence 0001213900-14-003374 |
| FY 2012 | $-15.8M | 2008-11-04 – 2013-03-31 | evidence 0001213900-13-002591 |
| FY 2011 | $-13.7M | 2008-11-04 – 2012-03-31 | evidence 0001213900-12-002597 |
| FY 2010 | $-827.0k | 2010-01-01 – 2010-12-31 | evidence 0001213900-12-001503 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
PATHFINDER CELL THERAPY, INC. — all facts · Revenue · Net Income